| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.28 | 0.3 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | -0.25 | 4e-05 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | -0.21 | 0.0008 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | -0.21 | 2e-07 |
| mRNA | FMK | GDSC1000 | pan-cancer | AAC | -0.19 | 2e-05 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.18 | 1e-05 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.15 | 4e-05 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | -0.15 | 3e-05 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.14 | 0.02 |
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.3 |